| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/21/2004 | US6794409 Homosteroids such as 17-chloro-17a-alpha-ethinyl-17a, 18a-dihomo-estra-1,3,5(10),16-tetraene-3,17a beta-diol; without use of progestin; contraception; for treatment of proliferative diseases of the ovary |
| 09/21/2004 | US6794407 Methods for treating circadian rhythm phase disturbances |
| 09/21/2004 | US6794402 Bicyclic cyclohexylamines and their use as NMDA receptor antagonists |
| 09/21/2004 | US6794393 Tyrosine kinase inhibitors |
| 09/21/2004 | US6794377 Ortho, ortho-substituted nitrogen-containing bisaryl compounds, useful for the treatment and prophylaxis of atrial arrhymias, e.g. atrail fibrillation or atrial flutters |
| 09/21/2004 | US6794373 Contraceptive methods using benzimidazolones |
| 09/21/2004 | US6794363 Isolated amyloid inhibitor protein (APIP) and compositions thereof |
| 09/21/2004 | US6794360 Using histacalin protein in the manufacture of a medicament for the treatment or prevention of allergic rhinitis |
| 09/21/2004 | US6794178 Nucleotide sequences coding transport protein for us in the treatment and diagnosis of cancer, arthritis, vision defects and skin dsorders |
| 09/21/2004 | US6794169 Enzymatic polypeptide for use in the biosynthesis of glycans |
| 09/21/2004 | US6794137 Detecting exposure of a cell to ultraviolet radiation; obtain cells, screen for preferential gene expression, monitor cells for adjusted tubulin protein expression |
| 09/21/2004 | US6793942 An analgesic, antiinflammatory pharmaceutical and a nutraceutical in a base at least one of which treats a condition caused by an immune response that triggers the cough reflex |
| 09/21/2004 | US6793939 Tissue graft composition comprising liver basement membrane; graft composition can be implanted to replace or induce repair of damaged or diseased tissues |
| 09/21/2004 | US6793919 Methods for treating rheumatoid arthritis using IL-17 antagonists |
| 09/21/2004 | US6793912 Treatment of cancers by inhalation of stable platinum-containing formulations |
| 09/21/2004 | CA2458085A1 Transcriptional activity assay |
| 09/18/2004 | CA2433205A1 Drug delivery, bodily fluid drainage, and biopsy device with enhanced ultrasonic visibility |
| 09/16/2004 | WO2004078745A1 Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders |
| 09/16/2004 | WO2004078178A1 Buprenorphine compounds for treatment of alcohol dependence and excessive alcohol use |
| 09/16/2004 | WO2004078170A1 Potassium taurate bicarbonate and ascorbate complexes |
| 09/16/2004 | WO2004078157A2 Regulation of mammalian hair growth |
| 09/16/2004 | WO2004078139A2 Therapeutic compositions |
| 09/16/2004 | WO2004078133A2 Antineoplastic combinations comprising a rapamycin derivative and an aromatase inhibitor |
| 09/16/2004 | WO2004078127A2 Continuous delivery methods for treating hepatitis virus infection |
| 09/16/2004 | WO2004078122A2 Invisible patch for active agnet controlled delivery |
| 09/16/2004 | WO2004078117A2 Method for increasing hair growth |
| 09/16/2004 | WO2004078113A2 Treatment and prevention of obesity with cox-2 inhibitors alone or in combination with weight-loss agents |
| 09/16/2004 | WO2004078108A2 Fibrate tablet and method for the production thereof |
| 09/16/2004 | WO2004078022A2 Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues |
| 09/16/2004 | WO2004077938A2 Novel chemical entities and methods for their use in treatment of metabolic disorders |
| 09/16/2004 | WO2004052295A3 Compositions and methods for nutrition supplementation |
| 09/16/2004 | WO2004050096A3 Phosphoantigens for regulating an immune response |
| 09/16/2004 | WO2004041272A3 Use of serotonin receptor antagonists for the treatment of sleep apnea |
| 09/16/2004 | WO2003090682A3 Treatment and prevention of pulmonary conditions |
| 09/16/2004 | WO2003088918A3 PHARMACEUTICAL COMPOSITIONS CONTAINING α3β4 NICOTINIC RECEPTOR ANTAGONISTS AND METHODS OF THEIR USE |
| 09/16/2004 | WO2003088898A3 Compositions and methods for the diagnosis and treatment of tumor |
| 09/16/2004 | WO2003073989A3 Nucleoside 5'-monophosphate mimics and their prodrugs |
| 09/16/2004 | WO2003066063A8 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist |
| 09/16/2004 | WO2003052048A3 Nucleic acid-associated proteins |
| 09/16/2004 | WO2003028729A3 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 09/16/2004 | WO2002100827A3 Method for increasing the survival of dopamine secreting cells |
| 09/16/2004 | WO2002099043A8 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 09/16/2004 | US20040181125 Cardiac disease treatment and device |
| 09/16/2004 | US20040181123 Cardiac disease treatment and device |
| 09/16/2004 | US20040181122 Cardiac disease treatment and device |
| 09/16/2004 | US20040181121 Cardiac disease treatment and device |
| 09/16/2004 | US20040181059 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 09/16/2004 | US20040181047 33 human secreted proteins |
| 09/16/2004 | US20040181037 Phosphatidyl serine receptors and uses thereof |
| 09/16/2004 | US20040180959 --title-- |
| 09/16/2004 | US20040180958 Method of treatment |
| 09/16/2004 | US20040180955 to establish a low circulating concentration of suramin in the patient of below about 200 mu, then administering cytotoxic agent |
| 09/16/2004 | US20040180946 Phenyl-indole compounds for modulating IgE and inhibiting cellular proliferation |
| 09/16/2004 | US20040180934 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists |
| 09/16/2004 | US20040180923 obesity, diabetes, male sexual dysfunction, and female sexual dysfunction |
| 09/16/2004 | US20040180918 PDE 4 inhibitor (cilomilast) and an anticholinergic agent (tiotropium); asthma; copd |
| 09/16/2004 | US20040180916 Treatment of pain with combinations of nalbuphine and other kappa-opioid receptor agonists and opioid receptor antagonists |
| 09/16/2004 | US20040180888 Phenylindoles for the treatment of HIV |
| 09/16/2004 | US20040180879 Novel method of treating vasomotor symptoms |
| 09/16/2004 | US20040180876 Selective beta 2-adrenoreceptor agonists; rapid onset of action, long duration; such as 3-(4-{[6-{(-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)hexyl]oxy}butyl)benzenesulfonamide; synthesis |
| 09/16/2004 | US20040180868 Using leukotriene inhibitor, antihistamine and/or corticosteroid; sinus infections |
| 09/16/2004 | US20040180862 Combination of farnesyl diphosphate synthase inhibiting bisphosphonate and squalene synthase inhibitor; counteracting adverse gastrointestinal effects |
| 09/16/2004 | US20040180857 dopamine reuptake inhibitors; for treatment of thoratic outlet obstruction syndrome |
| 09/16/2004 | US20040180843 Treatment of helicobacter with isothocyanates |
| 09/16/2004 | US20040180836 Blocking peptide for inflammatory cell secretion |
| 09/16/2004 | US20040180834 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 09/16/2004 | US20040180829 Compounds and methods for regulating bacterial growth and pathogenesis |
| 09/16/2004 | US20040180824 Combination treatment using exendins and thiazolidinediones |
| 09/16/2004 | US20040180816 Combination comprising a p-gp inhibitor and an anti-epileptic drug |
| 09/16/2004 | US20040180812 Methods of treating and preventing proliferative disease |
| 09/16/2004 | US20040180434 Materials and methods for nerve grafting, selection of nerve grafts, and in vitro nerve tissue culture |
| 09/16/2004 | US20040180407 Novel G protein coupled receptor protein, DNA and its ligand |
| 09/16/2004 | US20040180392 Identifying statins susceptible to glucoronyl oxidation catalyzed by glucuronyltransferase and non-statin pharmeceutical which inhibit glucoronidation via binding peroxisome proliferator activated receptors for treating and preventing coronary heart disease; side effect reduction |
| 09/16/2004 | US20040180354 Comprises polypeptides which are displayable on antigen presenting cells of immune system for use in prevention and treatment of infection and vaccine development; immunotherapy |
| 09/16/2004 | US20040180338 Mutated eukariotic transalation initiation factor 2 alpha kinase3, eif2ak3, in patients with neonatal insuluin-dependant diabetes and multiple epiphyseal dyslapsia (wolcott-rallison syndrome) |
| 09/16/2004 | US20040180106 Proteoglycan compositions for treatment of inflammator diseases |
| 09/16/2004 | US20040180102 Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto |
| 09/16/2004 | US20040180099 Method of reducing toxicity of anticancer agents |
| 09/16/2004 | US20040180089 Multilayer dosage forms containing NSAIDs and triptans |
| 09/16/2004 | US20040180072 Prosthesis with sustained release analgesic |
| 09/16/2004 | US20040180052 Bind to AILIM (activation inducible lymphocyte immunomodulatory molecule, also referred to as ICOS (inducible co-stimulator); human monoclonal antibodies which bind to AILIM or a portion thereof; for treating disorders related to the delayed allergy |
| 09/16/2004 | US20040180035 Administering to the mammal (i) an immunoconjugate comprising an antibody binding site capable of binding the preselected cell-type and a cytokine capable of inducing a said immune response against the preselected cell-type, and (ii) an angiogenesis inhibitor to enhance immune response |
| 09/16/2004 | US20040180034 Anthelmintic resinates and a method for their preparation |
| 09/16/2004 | US20040180015 Also containing an alpha hydroxyl acid or phosphoric acid |
| 09/16/2004 | US20040180003 comprises assessing changes in gene expression levels, levels of nucleic acids, proteins, or protein activity levels and determining whether the compound mimics effects induced by the CR diet program. |
| 09/16/2004 | US20040180001 antitumor |
| 09/16/2004 | DE20220964U1 Composition containing antioxidants and micronutrients, useful for treatment or prevention of paradontitis and associated disorders, also osteoporosis |
| 09/16/2004 | CA2517929A1 Novel-chemical entities and methods for their use in treatment of metabolic disorders |
| 09/16/2004 | CA2517916A1 Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues |
| 09/16/2004 | CA2517537A1 Potassium taurate bicarbonate and ascorbate complexes |
| 09/16/2004 | CA2517088A1 Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders |
| 09/16/2004 | CA2516500A1 Regulation of mammalian hair growth |
| 09/16/2004 | CA2516353A1 Antineoplastic combinations comprising a rapamycin derivative and an aromatase inhibitor |
| 09/16/2004 | CA2515098A1 Invisible patch for active agent controlled delivery |
| 09/15/2004 | EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 09/15/2004 | EP1457213A1 Anthelmintic resinates and a method for their preparation |
| 09/15/2004 | EP1457172A1 Joint prosthesis with substained release of a therapeutic agent |
| 09/15/2004 | EP1456670A2 Methods relating to treatment of atherosclerosis |
| 09/15/2004 | EP1456653A2 Genes encoding g-protein coupled receptors and methods of use therefor |
| 09/15/2004 | EP1456650A2 Gfats as modifiers of the p53 pathway and methods of use |